PFE Analyst Insights

Ratings	Buy	Hold	Sell	Other ratings	Last Close	Average Target	Upside	High Target	Low Target
(m)	(m)	(m)	(m)	(m)	$29.39	(m)	(m)	(m)	(m)

Date	Stock	Analyst	Firm	Price When Rated	Price Target	Upside / Downside	Rating
2026-02-19	PFE PFIZER INC	Emily Field, CFA	Barclays	$27.37	$25.00	-8.66%	Underweight
2024-11-29	PFE PFIZER INC	Emily Field, CFA	Barclays	$25.83			Equal Weight
2024-07-30	PFE PFIZER INC	Emily Field, CFA	Barclays	$30.72	$32.00	+4.17%	Equal Weight
2024-07-10	PFE PFIZER INC	Emily Field, CFA	Barclays	$27.72	$30.00	+8.23%	Equal Weight
2023-12-13	PFE PFIZER INC	Emily Field, CFA	Barclays	$26.66	$28.00	+5.03%	Equal Weight
2023-10-31	PFE PFIZER INC	Emily Field, CFA	Barclays	$30.56	$34.00	+11.26%	Equal Weight
2023-10-02	PFE PFIZER INC	Emily Field, CFA	Barclays	$33.94	$35.00	+3.12%	Equal Weight

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64